002610.SZ SHZ
Jiangsu Akcome Science and Technology Co., Ltd.
1W: -21.3%
1M: -64.8%
3M: -82.5%
1Y: -85.0%
3Y: -84.8%
5Y: -80.9%
¥0.37
Last traded 2024-06-18 — delisted
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$4.7B
-30.3% ▼
5Y CAGR: -0.8%
Gross Profit
$274M
+536.3% ▲
5Y CAGR: -20.6%
Operating Income
-$226M
+72.9% ▲
Net Income
-$826M
+0.1% ▲
EPS (Diluted)
$-0.18
+5.3% ▲
EBITDA
-$724M
-40.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $5.1B | $3.0B | $2.5B | $6.7B | $4.7B |
| YoY Growth | +5.9% | -41.2% | -16.1% | +164.3% | -30.3% |
| Cost of Revenue | $4.4B | $2.6B | $2.5B | $6.8B | $4.4B |
| Gross Profit | $742M | $449M | $62M | -$63M | $274M |
| Gross Margin | 14.5% | 14.9% | 2.4% | -0.9% | 5.9% |
| R&D Expenses | $41M | $38M | $39M | $73M | $79M |
| SG&A Expenses | $302M | $139M | $157M | $188M | $178M |
| Operating Expenses | $451M | $280M | $332M | $254M | $1.2B |
| Operating Income | -$248M | $447M | -$81M | -$836M | -$226M |
| Operating Margin | -4.8% | 14.8% | -3.2% | -12.5% | -4.8% |
| Interest Expense | $427M | $385M | $258M | $215M | $34M |
| Income Before Tax | -$1.6B | -$37M | -$520M | -$913M | -$948M |
| Tax Expense | $31M | -$66M | -$100M | -$86M | -$54M |
| Net Income | -$1.7B | $30M | -$420M | -$827M | -$826M |
| Net Margin | -32.6% | 1.0% | -16.6% | -12.4% | -17.7% |
| EPS (Diluted) | $-0.37 | $0.01 | $-0.09 | $-0.19 | $-0.18 |
| EBITDA | -$917M | $594M | $56M | -$515M | -$724M |
| Shares Outstanding | 4.48B | 4.48B | 4.48B | 4.47B | 4.48B |